BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6531300)

  • 1. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
    Fischer E; Schnyder UW; Jung EG
    Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
    Thielmann HW; Popanda O; Edler L; Jung EG
    Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
    Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
    Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
    Kondo S; Satoh Y; Kuroki T
    Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic complementation group analysis of xeroderma pigmentosum patients in China].
    Qiang K; Zhang Y; Han Z; You Y; Jiao H; Xu F; Xu P; Sun L; Ho Z; Peng L; Yu Z; Ikenage M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):285-9. PubMed ID: 10514532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum complementation group E: a case report.
    Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan.
    Takebe H; Miki Y; Kozuka T; Furuyama JI; Tanaka K
    Cancer Res; 1977 Feb; 37(2):490-5. PubMed ID: 832273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The determination of the complementation groups for the cells of patients with xeroderma pigmentosum and the Cockayne syndrome found in Russia].
    Pleskach NM; Mikhel'son VM; Raams A; Bootsma D
    Tsitologiia; 1996; 38(8):863-8. PubMed ID: 9027016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate stimulates cellular recovery from UV damage in xeroderma pigmentosum cells belonging to complementation group F.
    Nishigori C; Takebe H
    Jpn J Cancer Res; 1987 Sep; 78(9):932-6. PubMed ID: 3117749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No apparent neurologic defect in a patient with xeroderma pigmentosum complementation group D.
    Ichihashi M; Yamamura K; Hiramoto T; Fujiwara Y
    Arch Dermatol; 1988 Feb; 124(2):256-60. PubMed ID: 3341805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
    Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
    Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of two Japanese xeroderma pigmentosum patients to complementation group D and their characteristics.
    Fujiwara Y; Satoh Y
    Jpn J Cancer Res; 1985 Mar; 76(3):162-6. PubMed ID: 3922833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
    Daya-Grosjean L; Sarasin A
    Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic basis of xeroderma pigmentosum.
    Bootsma D; Hoeijmakers JH
    Ann Genet; 1991; 34(3-4):143-50. PubMed ID: 1809220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.